Posted on 6/4/18
Cordental Acquires Drs. Melman, Ravett & Associates
CRDENTAL Group, a portfolio company of NMS Capital, announced today that it has affiliated with Barry Melman, DMD and Stephanie Ravett, DMD of Drs. Melman, Ravett . . .
Posted on 6/3/18
Better Buy: Biogen Inc. vs. Celgene
Investors haven't been happy with either Biogen (NASDAQ:BIIB) or Celgene (NASDAQ:CELG)lately. But the level of discontent is much higher with Celgene. The biotech stock has dropped . . .
Posted on 6/1/18
How Do You Feel About Johnson & Johnson?: Part IV - Today's Editors' Picks
Last week, we published a daily asking readers to choose a single "best" stock for the next decade. Conglomerate Johnson & Johnson (NYSE:JNJ) was a favorite. . . .
Posted on 6/1/18
Teva - Reasonable Start To 2018 Alleviates Immediate Concerns
Teva Pharmaceutical Industries (TEVA) has made great efforts in stabilising the business. In December of last year, I concluded that aggressive cost cuts provide relief to . . .
Posted on 6/1/18
Vibra Healthcare Enters Partnership to Combine Ernest Health and Certain Vibra Healthcare Assets
Vibra Healthcare, LLC, a post-acute care provider, today announced it has reached an agreement to form a partnership consisting of Ernest Health, Inc. ("Ernest"), and several . . .
Posted on 6/1/18
Why These Biotech Startups Are Facing A 550% Rent Hike
The way CEO Briana Wronko sees it, the University City Science Center and Boston-based Cambridge
Posted on 5/31/18
Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility
EAST RUTHERFORD, N.J., May 31, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today . . .
Posted on 5/31/18
Interpace Diagnostics Enters into Agreement with Nationally Renowned Institution
PARSIPPANY, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically . . .
Posted on 5/31/18
Akers Biosciences Granted 180-Day Extension by Nasdaq
THOROFARE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L),, a developer of rapid health information technologies, announces that, on May . . .
Posted on 5/29/18
Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA
NORTHVALE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc (OTCBB:ELTP) announced today the signing of a license, manufacturing, and supply agreement with Glenmark Pharmaceuticals, . . .
Posted on 5/28/18
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
THOROFARE, N.J., May 25, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), a developer of rapid health information technologies, announces that it received . . .
Posted on 5/25/18
Campbell Soup: Mmm Mmm Capitulation
With an earnings release that had almost nothing good in it, including an earnings guidance reduction, impairment charges, unforeseen merger integration headwinds, a CEO that abruptly . . .
Posted on 5/25/18
Celgene Corp. Announces Additional $3 Billion Share Repurchase Authorization
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced that the Company's Board of Directors authorized the repurchase of an additional $3 billion of the Company's common . . .
Posted on 5/25/18
VWR Named Sole Supplier for Cell and Gene Therapy Catapult
VWR, acquired by Avantor in 2017 as a wholly-owned subsidiary and a leading global provider of product and service solutions to laboratory and production customers, has . . .
Posted on 5/25/18
UnitedHealthcare Establishes Long-Term Strategic Partnership with Quest Diagnostics
MINNEAPOLIS & SECAUCUS, N.J.--(BUSINESS WIRE)--UnitedHealthcare and Quest Diagnostics (NYSE: DGX) have established a long-term strategic partnership as the two organizations focus on ways to create more . . .
Posted on 5/24/18
ContraVir Pharmaceuticals Announces Reverse Stock Split
EDISON, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the . . .
Posted on 5/24/18
Recro Pharma Receives Complete Response Letter from the FDA
MALVERN, Penn., May 24, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other . . .
Posted on 5/24/18
Fibrocell Announces One-for-Five Reverse Stock Split
EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective . . .
Posted on 5/24/18
Novartis' Remicade Biosimilar OK'd In Europe
The European Commission approves Novartis (NYSE:NVS) unit Sandoz's Zessly (infliximab), a biosimilar of Johnson & Johnson's (NYSE:JNJ) Remicade.READ FULL ARTICLE HERE
Posted on 5/24/18
Merck (MRK) Investor Presentation - Slideshow
The following slide deck was published by Merck & Co Inc. in conjunction with this event. 130READ FULL ARTICLE HERE
Posted on 5/24/18
Better Buy: AbbVie Inc. vs. Pfizer Inc.
If you're looking to buy a big pharma stock, both AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE)have a lot to offer. AbbVie has been the bigger winner in . . .
Posted on 5/24/18
J&J Loses Second Verdict in Talc Asbestos Cancer Case
Johnson & Johnson (NYSE:JNJ) and its talc suppliers were hit today with a $21.7M jury verdict in JNJ's second trial loss over allegations that its talc-based . . .
Posted on 5/24/18
Regional Cancer Care Associates Recognized for Quality in Value Based Cancer Care
Regional Cancer Care Associates (RCCA) has been recognized with a Blue Distinction® Centers for Cancer Care designation as part of the Blue Distinction Specialty Care program. . . .
Posted on 5/24/18
Strados Labs Wins $10,000 From Cisco For Respiratory Device
Strados Labs was named a runner-up in Cisco’s 2018 Global Problem Solver Challenge.
Posted on 5/23/18
Verrica Pharmaceuticals Readies IPO
West Chester, PA-based Verrica Pharmaceuticals (VRCA) files a prospectus for its U.S. debut.The clinical-stage firm develops treatments for skin diseases. Lead candidate is VP-102, a drug-device . . .

